These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 23142085)
21. Antimicrobial activity of SMAP-29 against the Bacteroides fragilis group and clostridia. Arzese A; Skerlavaj B; Tomasinsig L; Gennaro R; Zanetti M J Antimicrob Chemother; 2003 Sep; 52(3):375-81. PubMed ID: 12917245 [TBL] [Abstract][Full Text] [Related]
22. In vitro activity of 11 antibiotics against 74 anaerobes isolated from pediatric intra-abdominal infections. Goldstein EJ; Citron DM; Vaidya SA; Warren YA; Tyrrell KL; Vreni Merriam C; Fernandez H Anaerobe; 2006 Apr; 12(2):63-6. PubMed ID: 16701615 [TBL] [Abstract][Full Text] [Related]
23. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin. Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128 [TBL] [Abstract][Full Text] [Related]
24. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility]. Rodríguez E; Gamboa MM; Rodríguez C; Vargas P Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405 [TBL] [Abstract][Full Text] [Related]
25. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003. Roberts SA; Shore KP; Paviour SD; Holland D; Morris AJ J Antimicrob Chemother; 2006 May; 57(5):992-8. PubMed ID: 16507560 [TBL] [Abstract][Full Text] [Related]
29. [Antimicrobial activity of ornidazole and 6 other antibiotics against anaerobic bacteria]. Alados JC; Martínez-Brocal A; Miranda C; Rojo MD; García V; Domínguez MC; de la Rosa M Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):219-22. PubMed ID: 1863621 [TBL] [Abstract][Full Text] [Related]
30. [In vitro activity of 10 antibiotics including pristinamycin and its two components (RP 12536 and 27404) against strict anaerobes]. Dubreuil L; Houcke I; Singer E Pathol Biol (Paris); 1998 Feb; 46(2):147-52. PubMed ID: 9769928 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice. Thadepalli H; Chuah SK; Gollapudi S Chemotherapy; 2004 Jun; 50(2):76-80. PubMed ID: 15211081 [TBL] [Abstract][Full Text] [Related]
32. In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strains. Betriu C; Sánchez A; Palau ML; Gómez M; Picazo JJ Antimicrob Agents Chemother; 2001 Aug; 45(8):2372-4. PubMed ID: 11451700 [TBL] [Abstract][Full Text] [Related]
33. In Vitro Anaerobic Pharmacokinetic/Pharmacodynamic Model to Simulate the Bactericidal Activity of Levornidazole Against Bacteroides fragilis. Hu J; Zhang J; Chen Y; Liang W; Wu S Clin Ther; 2017 Apr; 39(4):828-836. PubMed ID: 28363695 [TBL] [Abstract][Full Text] [Related]
35. Changes in prevalence and susceptibility of obligate anaerobes in clinical veterinary practice. Hirsh DC; Indiveri MC; Jang SS; Biberstein EL J Am Vet Med Assoc; 1985 May; 186(10):1086-9. PubMed ID: 3997623 [TBL] [Abstract][Full Text] [Related]
36. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates. Schaumann R; Petzold S; Fille M; Rodloff AC Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869 [TBL] [Abstract][Full Text] [Related]
37. The bactericidal action of human serum on Bacteroides species. Rotimi VO; Eke PI J Med Microbiol; 1984 Dec; 18(3):355-63. PubMed ID: 6502677 [TBL] [Abstract][Full Text] [Related]
38. Anaerobic neonatal meningitis: A diagnostic challenge. de A Silva C; Dias L; Cardona RSB; Variane GFT; do Nascimento SD; de Oliveira SRP; Richtmann R Anaerobe; 2020 Feb; 61():102134. PubMed ID: 31838318 [TBL] [Abstract][Full Text] [Related]
39. Infective endocarditis due to multiple species of anaerobes following tricuspid valve replacement. Cho Y; Minami K; Kasai M; Kubota N; Higuchi T J Microbiol Immunol Infect; 2017 Oct; 50(5):733-734. PubMed ID: 27553447 [No Abstract] [Full Text] [Related]
40. In vitro bactericidal activity and post-antibiotic effect of ABT-773 versus co-amoxiclav against anaerobes. Pendland SL; Neuhauser MM; Prause JL J Antimicrob Chemother; 2002 May; 49(5):879-81. PubMed ID: 12003989 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]